Transcriptomics

Dataset Information

0

Radiation combined with KRAS-MEK inhibitors enhances anticancer immunity in KRAS-mutated tumor models

ABSTRACT: This SuperSeries is composed of the SubSeries listed below.

ORGANISM(S): Mus musculus

PROVIDER: GSE209767 | GEO | 2022/10/01

REPOSITORIES: GEO

Json Xml

Similar Datasets

Transcriptomics Radiation combined with KRAS-MEK inhibitors enhances anticancer immunity in KRAS-mutated tumor models [LLC RNA-seq]
2022-10-01 | GSE209766 | GEO
Transcriptomics Radiation combined with KRAS-MEK inhibitors enhances anticancer immunity in KRAS-mutated tumor models [CT26 RNA-seq]
2022-10-01 | GSE209765 | GEO
Unknown MicroRNA-16 Restores Sensitivity to Tyrosine Kinase Inhibitors and Outperforms MEK Inhibitors in KRAS-Mutated Non-Small Cell Lung Cancer.
| S-EPMC8705178 | biostudies-literature
Unknown Combined inhibition of MEK and Aurora A kinase in KRAS/PIK3CA double-mutant colorectal cancer models.
| S-EPMC4468631 | biostudies-literature
Unknown Tumor suppressor miR-193a-3p enhances efficacy of BRAF/MEK inhibitors in BRAF-mutated colorectal cancer.
| S-EPMC8409311 | biostudies-literature
Unknown Synergistic effect of the inhibitors of RAF/MEK and AXL on KRAS-mutated ovarian cancer cells with high AXL expression.
| S-EPMC7293078 | biostudies-literature
Unknown Dual targeting of PI3K and MEK enhances the radiation response of K-RAS mutated non-small cell lung cancer.
| S-EPMC5190057 | biostudies-literature
Unknown Synthetic lethal interaction of combined BCL-XL and MEK inhibition promotes tumor regressions in KRAS mutant cancer models.
| S-EPMC3667614 | biostudies-literature
Unknown Dual Inhibition of MEK and PI3K Pathway in KRAS and BRAF Mutated Colorectal Cancers.
| S-EPMC4613347 | biostudies-literature
Unknown Combination of PI3K and MEK inhibitors yields durable remission in PDX models of PIK3CA-mutated metaplastic breast cancers.
| S-EPMC7036180 | biostudies-literature